TerminatedNCT06431256

Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years With ADHD

Medication studyAges 4–5United States

The study in practice

Understand this study

Who could participate?

Listed age limits: 4 years to 5 years.

Listed locations: Dothan, United States · Anaheim, United States and 11 more locationsSee all locations and recruitment
Activities: Medication described in the protocol · Placebo comparator
Compensation: Payment and expense reimbursement have not been verified.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: September 13, 2024

Recruitment status: Terminated
Enrollment listed in the registry: 26
Sponsor: Ironshore Pharmaceuticals and Development, Inc
Sponsor type: Other organization
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 3
Locations: United States
Age range: From 4 Years to 5 Years
Official registry ID: NCT06431256
Official title: Show the full official title
Phase 3, Multicenter, 3-Week Fixed-dose, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy, Safety and PK Study of Evening Dosed Methylphenidate Hydrochloride ER Capsules (HLD200) in Children Aged 4-5 Years With ADHD

Need help understanding this study?

Leave your email and we’ll get in touch to discuss your questions and possible next steps.

Recruitment & locations

Terminated

Dothan · Anaheim · Jacksonville

10 more locations

Miami Springs
Orlando
Decatur
New Orleans
Saint Charles
Lincoln
Las Vegas
Cincinnati
Summerville
Memphis

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Ironshore Pharmaceuticals and Development, Inc.

Does this study involve medication?

Yes. The study involves medication, including HLD200 methylphenidate hydrochloride capsules and Placebo HLD200 capsules.

Who can participate?

Listed age limits: 4 years to 5 years.

Is this study still recruiting?

The registry lists this study as terminated.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me